Copyright Reports & Markets. All rights reserved.

Global Drug Abuse Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Drug Abuse Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Opioid Addiction
      • 1.4.3 Tobacco/Nicotine Addiction
      • 1.4.4 Alcohol Dependence
    • 1.5 Market by Application
      • 1.5.1 Global Drug Abuse Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital & Clinics
      • 1.5.3 Residential (non-hospital)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Drug Abuse Treatment Market Size
    • 2.2 Drug Abuse Treatment Growth Trends by Regions
      • 2.2.1 Drug Abuse Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Drug Abuse Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Drug Abuse Treatment Market Size by Manufacturers
      • 3.1.1 Global Drug Abuse Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Drug Abuse Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Drug Abuse Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Drug Abuse Treatment Key Players Head office and Area Served
    • 3.3 Key Players Drug Abuse Treatment Product/Solution/Service
    • 3.4 Date of Enter into Drug Abuse Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Drug Abuse Treatment Market Size by Type (2014-2019)
    • 4.2 Global Drug Abuse Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Drug Abuse Treatment Market Size (2014-2019)
    • 5.2 Drug Abuse Treatment Key Players in United States
    • 5.3 United States Drug Abuse Treatment Market Size by Type
    • 5.4 United States Drug Abuse Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Drug Abuse Treatment Market Size (2014-2019)
    • 6.2 Drug Abuse Treatment Key Players in Europe
    • 6.3 Europe Drug Abuse Treatment Market Size by Type
    • 6.4 Europe Drug Abuse Treatment Market Size by Application

    7 China

    • 7.1 China Drug Abuse Treatment Market Size (2014-2019)
    • 7.2 Drug Abuse Treatment Key Players in China
    • 7.3 China Drug Abuse Treatment Market Size by Type
    • 7.4 China Drug Abuse Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Drug Abuse Treatment Market Size (2014-2019)
    • 8.2 Drug Abuse Treatment Key Players in Japan
    • 8.3 Japan Drug Abuse Treatment Market Size by Type
    • 8.4 Japan Drug Abuse Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Drug Abuse Treatment Market Size (2014-2019)
    • 9.2 Drug Abuse Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Drug Abuse Treatment Market Size by Type
    • 9.4 Southeast Asia Drug Abuse Treatment Market Size by Application

    10 India

    • 10.1 India Drug Abuse Treatment Market Size (2014-2019)
    • 10.2 Drug Abuse Treatment Key Players in India
    • 10.3 India Drug Abuse Treatment Market Size by Type
    • 10.4 India Drug Abuse Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Drug Abuse Treatment Market Size (2014-2019)
    • 11.2 Drug Abuse Treatment Key Players in Central & South America
    • 11.3 Central & South America Drug Abuse Treatment Market Size by Type
    • 11.4 Central & South America Drug Abuse Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Indivior
      • 12.1.1 Indivior Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Drug Abuse Treatment Introduction
      • 12.1.4 Indivior Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.1.5 Indivior Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Drug Abuse Treatment Introduction
      • 12.2.4 Pfizer Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Alkermes
      • 12.3.1 Alkermes Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Drug Abuse Treatment Introduction
      • 12.3.4 Alkermes Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.3.5 Alkermes Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Drug Abuse Treatment Introduction
      • 12.4.4 Novartis Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Mylan
      • 12.5.1 Mylan Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Drug Abuse Treatment Introduction
      • 12.5.4 Mylan Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.5.5 Mylan Recent Development
    • 12.6 Cipla
      • 12.6.1 Cipla Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Drug Abuse Treatment Introduction
      • 12.6.4 Cipla Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.6.5 Cipla Recent Development
    • 12.7 Glenmark
      • 12.7.1 Glenmark Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Drug Abuse Treatment Introduction
      • 12.7.4 Glenmark Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.7.5 Glenmark Recent Development
    • 12.8 Dr. Reddy's Laboratories
      • 12.8.1 Dr. Reddy's Laboratories Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Drug Abuse Treatment Introduction
      • 12.8.4 Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.8.5 Dr. Reddy's Laboratories Recent Development
    • 12.9 Teva Pharmaceutical
      • 12.9.1 Teva Pharmaceutical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Drug Abuse Treatment Introduction
      • 12.9.4 Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.9.5 Teva Pharmaceutical Recent Development
    • 12.10 PLIVA (Odyssey)
      • 12.10.1 PLIVA (Odyssey) Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Drug Abuse Treatment Introduction
      • 12.10.4 PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2014-2019)
      • 12.10.5 PLIVA (Odyssey) Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
      Factors such as frequent product launches, approval and robust pipeline of novel biopharmaceutical products, growing patient awareness, higher treatment seeking rate, growing government recognition and intervention of the issue, as well as encouragement to curb substance abuse in all countries are driving the growth of drug abuse treatment market globally.
      In 2018, the global Drug Abuse Treatment market size was 14500 million US$ and it is expected to reach 22700 million US$ by the end of 2025, with a CAGR of 6.6% during 2019-2025.

      This report focuses on the global Drug Abuse Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Abuse Treatment development in United States, Europe and China.

      The key players covered in this study
      Indivior
      Pfizer
      Alkermes
      Novartis
      Mylan
      Cipla
      Glenmark
      Dr. Reddy's Laboratories
      Teva Pharmaceutical
      PLIVA (Odyssey)

      Market segment by Type, the product can be split into
      Opioid Addiction
      Tobacco/Nicotine Addiction
      Alcohol Dependence

      Market segment by Application, split into
      Hospital & Clinics
      Residential (non-hospital)

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Drug Abuse Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Drug Abuse Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Drug Abuse Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now